Research and Education

Solving the puzzle of cancer

Backing innovation for over 50 years

Many cancers today can be controlled or managed with new available therapies, but we are still looking for cures. When we started back in 1968, the word was barely spoken because of its deadly implications. Research has made that transformation possible, and our donors make those explorations happen. 

Our donors back novel research by our grantees, giving them the time and resources needed to take an intuitive idea into innovative breakthroughs. And those discoveries can take significant amounts of time. Whether it is translating new scientific information into advanced cancer management approaches or improving treatment delivery for better outcomes and quality of life, The Foundation’s grantees are doing work that can change patients’ lives.

 
Our grantees discover new paths

Early research
transforms lives

brain_tumors
Brain Tumors

Gliomas can occur in the brain and in various locations in the nervous system, including the brain stem and spinal column. Some tumors, after several months, become treatment resistant. TCF researchers are looking at the mechanisms behind this resistance.

breast_cancer
Breast Cancer

Our researchers are exploring different avenues to potentially more effective breast cancer treatments through hormone identification, radiation and immunotherapies, and the isolation of gene markers.

gi_cancers
GI Cancers

The relationship between irritable bowel disease and cancer has complicated treatment for patients. Our researchers are clarifying the approach.

hematology_oncology
Hematological Cancer

Blood cancers can be very resistant to treatment. Our researchers are tackling some of the basic science behind some of the genetic markers in order to find better treatments.

hodgkin
Hodgkin’s and Non-Hodgkin’s Lymphomas

Our researchers are finding breakthroughs in the treatment of these lymphatic system cancers that show promise for solid tumors as well.

leukemia
Leukemia

We are backing basic research into the complex interactions and molecular pathways behind leukemia in both adults and children.

melanomas
Malignant Melanomas

Exploring how the immune system does and doesn’t respond when there are genetic variations can help identify effective treatments in the future.

Current research

What we fund and why

The Chemotherapy Foundation understands that it takes decades for research to translate into treatment. Most of our researchers are funded for at least 5 to 10 years except for special one-time grants.

Our Medical Advisory Council creates a “Request for Proposals” in specific areas of oncology and contacts researchers and medical doctors at medical institutions in the Tri-state area. Our priority is emerging talent in oncology with a focus on funding translational and collaborative research projects that evolve into breakthrough interventions for changing the way cancer is treated. We do not accept unsolicited grant proposals. 

A history of funding breakthroughs

Identifying future developments for over 50 years